Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07470723

Opportunity to Reach Individuals With Genetic Dyslipidemia During Infancy and the Newborn Period to Find Familial Hypercholesterolemia

Led by University of Wisconsin, Madison · Updated on 2026-03-13

70

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are conducting the ORIGIN-FH study to identify different types of Familial Hypercholesterolemia (FH) in newborns and infants. This two-phase cohort study focuses on expectant parents where one or both partners have diagnosed or suspected heterozygous or homozygous FH. The goal is to prospectively screen and diagnose their newborns with HoFH, HeFH, or determine if they are unaffected by FH. Participants will provide cheek swabs for genetic testing (parents only) and newborns will have five blood samples collected for FH screening. The study will enroll newborns who meet specific inclusion criteria and will monitor their lipid profiles over time. The study spans two years, during which newborns will be screened and diagnosed for FH types. Throughout the two-year participation, researchers will collect blood samples and monitor cholesterol and lipoprotein levels at one month and two years of age. Outcomes include the number of diagnostically confirmed HoFH and HeFH newborns and changes in lipid markers such as LDL cholesterol, total cholesterol, apolipoprotein B, and lipoprotein A. Participants will comply with study procedures and may use local laboratory services or mobile phlebotomy for infant blood collections.

CONDITIONS

Brief Title

The ORIGIN-FH Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals in the expectant partnership providing informed consent are at least 18 years of age.
  • Ability to understand and willingness to sign a written informed consent document.
  • Willingness to comply with all study procedures and be available for the duration of the study.
  • Expectant parent currently pregnant with fetus at least 12 weeks gestation where one or both partners have been diagnosed with possible or definite HoFH or HeFH based on Dutch Lipid Clinic Network or confirmed diagnosis from a healthcare provider.
  • At minimum, at least one parent with HoFH or HeFH must be willing to consent to study participation; both parents are invited.
  • Parent(s) commit to using local laboratory services for infant blood samples or mobile phlebotomy if available.
  • Newborn does not have any congenital abnormalities or medical conditions that may interfere with collection of dried blood spot specimen.
  • Newborn does not require admission to neonatal intensive care unit.
Not Eligible

You will not qualify if you...

  • Expectant partnership where neither partner meets diagnostic criteria for HeFH or HoFH.
  • Parent refuses consent for newborn's study participation.
  • Newborn has medical condition precluding dried blood spot specimen collection.
  • Newborn's dried blood spot specimen is not collected by 1 week of age.
  • Not suitable for study participation due to other reasons at the discretion of the investigators.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

5 blood sample collections for screening

Diagnostic Evaluation

Duration - Up to 2 years

Newborns of eligible expectant parents are prospectively screened and diagnosed for familial hypercholesterolemia (FH).

Blood samples collected from newborns using local laboratory services or mobile phlebotomy

Trial Site Locations

Total: 1 location

1

University of Wisconsin - Madison

Madison, Wisconsin, United States, 53792

Actively Recruiting

Loading map...

Research Team

X

Xiao Zhang, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and...

Familial Hypercholesterolemia

Actively Recruiting

1 location

A Multicenter, Dose-exploration Study to Evaluate the Safety...

Homozygous Familial Hypercholesterolemia (HoFH)

Actively Recruiting

1 location

A Phase 1 Open-label, Multicenter Trial Evaluating Safety an...

Cardiovascular

Actively Recruiting

18 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here